Adjuvant application of trastuzumab in HER2 positive breast cancer and impact on time to relapse

Archive of Oncology · Published 2019-09-26 · DOI 10.2298/aoo181112006d

Authors being retrieved — see the publisher record. https://doi.org/10.2298/aoo181112006d

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2019

Related articles

• Emerging trends in immunotherapy and cancer pharmacology: Exploring novel therapeutic approaches in oncology · Archive of Oncology · 2026 · Same journal
• Trends in colon cancer incidence in young and older adults in Macva region (Serbia) · Archive of Oncology · 2022 · Same journal
• Late diagnosis of pheochromocytoma in pregnancy with poor fetal outcome · Archive of Oncology · 2020 · Same journal
• Assessment of pathological response to neoadjuvant chemotherapy in patients with breast carcinoma using Sataloff system · Archive of Oncology · 2019 · Same journal
• Acceptance of human papillomavirus self-testing in cervical cancer prevention among rural Nigerian women · Archive of Oncology · 2025 · Same journal
• Multidisciplinary surgical approach in the treatment of giant mucinous ovarian cystadenocarcinoma · Archive of Oncology · 2025 · Same journal
• The efficacy of durvalumab in locally advanced lung carcinoma · Archive of Oncology · 2025 · Same journal
• The role of immunohistochemical analysis in the diagnosis of lung metastases · Archive of Oncology · 2023 · Same journal
• Distribution of histopathological types of thyroid tumors in 1999-2015 compared to 1966-1988 year period · Archive of Oncology · 2019 · Same journal
• Programmed cell death protein-1 and other inhibitory receptors expressed by regulatory T cells as a restraining factor of checkpoint therapy · Archive of Oncology · 2025 · Same journal